BioForce Nanosciences Holdings, Inc. (BFNH)
USD 0.9
(0.0%)
USD 0.9
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -46.7 Thousand | -68.38 Thousand | -77.77 Thousand | -80.19 Thousand | -24.38 Thousand | -62.46 Thousand |
| Net Income | -471.95 Thousand | -485.51 Thousand | -501.95 Thousand | -158.4 Million | -46.53 Thousand | -67.73 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 158 Million | - | - |
| Change in working capital | 425.25 Thousand | 417.12 Thousand | 424.18 Thousand | 328.35 Thousand | 5999.00 | 4274.00 |
| Other non-cash items | -2251.00 | -423 Thousand | 1.22 | 158 Million | 16.15 Thousand | 998.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 46.6 Thousand | 58.01 Thousand | 49.01 Thousand | 67.16 Thousand | 47.88 Thousand | 77.53 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 100.00 | - | - | 47.88 Thousand | 77.53 Thousand |
| Other Financing Activities | 46.6 Thousand | 57.91 Thousand | 49.01 Thousand | 67.16 Thousand | 47.88 Thousand | 77.53 Thousand |
| Accounts receivables | - | - | - | - | 5735.00 | -1235.00 |
| Accounts payables | 2251.00 | -5915.00 | 1223.00 | -5158.00 | 4925.00 | 3426.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 423 Thousand | 423.04 Thousand | 422.96 Thousand | 333.51 Thousand | -4661.00 | 5509.00 |
| Cash at beginning of period | 734.00 | 11.1 Thousand | 39.86 Thousand | 52.89 Thousand | 29.39 Thousand | 14.32 Thousand |
| Cash at end of period | 638.00 | 734.00 | 11.1 Thousand | 39.86 Thousand | 52.89 Thousand | 29.39 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -96.00 | -10.37 Thousand | -28.76 Thousand | -13.03 Thousand | 23.5 Thousand | 15.06 Thousand |
| Free Cash Flow | -46.7 Thousand | -68.38 Thousand | -77.77 Thousand | -80.19 Thousand | -24.38 Thousand | -62.46 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -114.44 Thousand | -130.81 Thousand | -471.95 Thousand | -114.41 Thousand | -113.6 Thousand | -113.93 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 101.04 Thousand | 113.23 Thousand | 425.25 Thousand | 107.32 Thousand | 105.69 Thousand | 105.28 Thousand |
| Other non-cash items | 4702.00 | -7482.00 | -2251.00 | -1574.00 | 60.00 | 464.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 13.41 Thousand | 17.58 Thousand | 46.6 Thousand | 7038.00 | 7949.00 | 8613.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 75.00 | - | - | - | - | - |
| Other Financing Activities | 13.34 Thousand | 17.58 Thousand | 46.6 Thousand | 7038.00 | 7949.00 | 8613.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -4702.00 | 7482.00 | 2251.00 | 1574.00 | -60.00 | -464.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | 105.75 Thousand | 105.75 Thousand | 423 Thousand | 105.75 Thousand | 105.75 Thousand | 105.75 Thousand |
| Cash at beginning of period | 640.00 | 638.00 | 734.00 | 686.00 | 654.00 | 686.00 |
| Cash at end of period | 667.00 | 640.00 | 638.00 | 638.00 | 686.00 | 654.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 27.00 | 2.00 | -96.00 | -48.00 | 32.00 | -32.00 |
| Free Cash Flow | -13.39 Thousand | -17.58 Thousand | -46.7 Thousand | -7086.00 | -7917.00 | -8645.00 |
2607
VLSFINANCE
EVN
FANH
TOITF
HNDFDS